SenseIV combines wearable sensing, intelligent analytics, and wireless connectivity to deliver continuous monitoring of peripheral IV cannulation sites. Our system is designed to detect early signs of complications, enabling faster intervention and reducing preventable harm.
Near real-time risk analysis for early complication detection.
Secure data transmission without restricting patient movement.
24/7 automated IV site surveillance.
A low-profile wearable sensor is placed over the IV site, capturing multimodal physiological signals. Data is transmitted wirelessly to a bedside unit or ward-wide system, where intelligent algorithms generate a dynamic risk score. When predefined thresholds are met, clear alerts are issued to clinical staff.
Alerts can also integrate with ward dashboards, pagers, or hospital communication systems, depending on local infrastructure.
Unlike intermittent manual checks, SenseIV provides continuous, objective monitoring of IV site integrity.
In the UK, NHS policy is that manual checks of IV sites are conducted every 8 hours. This is more than enough time for problems to develop, and worsen, between checks—but in periods where workload or stress is high, cannulas can go unchecked for much longer. There are 5 key adverse events that SenseIV detects:
The introduction of harmful germs in the body after the cannula breaks the skin barrier.
The unintended movement of a cannula out of the vein, halting the flow of medication into the bloodstream.
The inflammation of the vein due to movement of the cannula, irritating medication or bacterial infection.
The inadvertent leakage of medication or fluid into tissue; this can cause swelling and skin discolouration.
The leakage of medication or fluid into the tissue with a high or low pH; this can cause blistering and tissue necrosis.
Studies estimate 35–69% of peripheral IVs cause one or more adverse events before IV therapy is completed.*
Over 2 billion peripheral IV cannulas are inserted globally each year, including approximately 25 million in the UK and an estimated 330 million in the United States1. Despite being one of the most common invasive procedures in healthcare, failure rates are reported at up to 35–69%2, leading to avoidable patient injury, extended hospital stays, litigation claims and significant system costs. Monitoring remains intermittent and manual, meaning complications are often detected only after harm has occurred.
References:
1. 2 billion globally: Marsh, N., Larsen, E. N., Ullman, A. J., Mihala, G., Cooke, M., Ray-Barruel, G., & Rickard, C. M. (2024). Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis. International Journal of Nursing Studies, 151, Article 104673. https://doi.org/10.1016/j.ijnurstu.2023.104673
25 million UK: NHS Clinical Evaluation Team. Clinical Review Safety Peripheral Intravenous Cannula. 2018. Link to report
330 million US: Blanco-Mavillard, I., Parra-García, G., Fernández-Fernández, I., Rodríguez-Calero, M. Á., Personat-Labrador, C., & Castro-Sánchez, E. (2020). Care of peripheral intravenous catheters in three hospitals in Spain: Mapping clinical outcomes and implementation of clinical practice guidelines. PLOS One, 15(10). https://doi.org/10.1371/journal.pone.0240086
2. 35–69% failure rate: Matthews R., Gavin N. C., Marsh N., Marquart-Wilson L., Keogh S. (2023). Peripheral intravenous catheter material and design to reduce device failure: A systematic review and meta-analysis. Infectious Diseases and Health, 28(4), 298–307. https://doi.org/10.1016/j.idh.2023.05.005
Marsh N., Webster J., Larsen E., Cooke M., Mihala G., Rickard C. M. (2017). Observational study
of peripheral intravenous catheter outcomes in adult hospitalized patients: A multivariable
analysis of peripheral intravenous catheter failure. Journal of Hospital Medicine.
https://doi.org/10.12788/jhm.2867
Helm, R. E., Klausner, J. D., Klemperer, J. D., Flint, L. M., & Huang, E. (2015). Accepted but
unacceptable: peripheral IV catheter failure. Journal of Infusion Nursing, 42(3), 151–164.
https://doi.org/10.1097/NAN.0000000000000100
Real-time monitoring for peripheral IVs. Minimising preventable patient harm to make IV therapy safer for everyone.
© 2025 MedTech. All rights reserved